268 related articles for article (PubMed ID: 11778970)
21. Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
Kern WV; Heiss M; Steinbach G
Clin Infect Dis; 2001 Mar; 32(5):832-5. PubMed ID: 11229856
[TBL] [Abstract][Full Text] [Related]
22. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
23. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Lehrnbecher T; Varwig D; Kaiser J; Reinhardt D; Klingebiel T; Creutzig U
Leukemia; 2004 Jan; 18(1):72-7. PubMed ID: 14586478
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications.
Engel A; Knoll S; Kern P; Kern WV
Infection; 2005 Oct; 33(5-6):380-2. PubMed ID: 16258872
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and laboratory evolution of the febrile neutropenia episodes in pediatric patients hospitalized in a Colombian hospital in 2007-2009].
Hurtado IC; Sánchez DP; Espinal DA; Garcés C
Rev Chilena Infectol; 2012 Dec; 29(6):672-6. PubMed ID: 23412039
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
Abrahamsson J; Påhlman M; Mellander L
Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
[TBL] [Abstract][Full Text] [Related]
27. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-5, interleukin-6, interleukin-8 and tumour necrosis factor-alpha levels obtained within 24-h of admission do not predict high-risk infection in children with febrile neutropenia.
Aggarwal R; Bansal D; Bansal F; Nanda N; Ray P; Trehan A; Marwaha RK
Indian J Med Microbiol; 2013; 31(3):226-9. PubMed ID: 23883706
[TBL] [Abstract][Full Text] [Related]
29. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
30. Strong inflammatory cytokine response in male and strong anti-inflammatory response in female kidney transplant recipients with urinary tract infection.
Sadeghi M; Daniel V; Naujokat C; Wiesel M; Hergesell O; Opelz G
Transpl Int; 2005 Feb; 18(2):177-85. PubMed ID: 15691270
[TBL] [Abstract][Full Text] [Related]
31. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
Miedema KG; Tissing WJ; Abbink FC; Ball LM; Michiels EM; van Vliet MJ; de Vries WY; Kamps WA; Norbruis OF; Fiocco M; de Groot-Kruseman HA; van de Wetering MD; de Bont ES
Eur J Cancer; 2016 Jan; 53():16-24. PubMed ID: 26700076
[TBL] [Abstract][Full Text] [Related]
32. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Accuracy of Interleukin-6, Interleukin-8, and Interleukin-10 for Predicting Bacteremia in Children with Febrile Neutropenia.
Şahbudak Bal Z; Karadaş Özdemir N; Şen S; Yılmaz Karapınar D; Azarsız E; Aydemir Ş; Vardar F
Turk J Haematol; 2017 Aug; 34(3):254-257. PubMed ID: 28148470
[TBL] [Abstract][Full Text] [Related]
34. Bloodstream infections in cancer patients with febrile neutropenia.
Feld R
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S30-3. PubMed ID: 18778919
[TBL] [Abstract][Full Text] [Related]
35. Bacteremia in childhood cancer.
Celkan T; Ozkan A; Apak H; Diren S; Can G; Yuksel L; Yildiz I
J Trop Pediatr; 2002 Dec; 48(6):373-7. PubMed ID: 12521283
[TBL] [Abstract][Full Text] [Related]
36. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
Roongpoovapatr P; Suankratay C
J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 levels in febrile, young children with and without occult bacteremia.
Strait RT; Kelly KJ; Kurup VP
Pediatrics; 1999 Dec; 104(6):1321-6. PubMed ID: 10585983
[TBL] [Abstract][Full Text] [Related]
38. Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia.
Riikonen P; Saarinen UM; Teppo AM; Metsärinne K; Fyhrquist F; Jalanko H
J Infect Dis; 1992 Aug; 166(2):432-6. PubMed ID: 1378873
[TBL] [Abstract][Full Text] [Related]
39. The changing epidemiology of bacteremia in neutropenic children with cancer.
Aquino VM; Pappo A; Buchanan GR; Tkaczewski I; Mustafa MM
Pediatr Infect Dis J; 1995 Feb; 14(2):140-3. PubMed ID: 7746697
[TBL] [Abstract][Full Text] [Related]
40. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
Cost CR; Stegner MM; Leonard D; Leavey P
J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]